Publications<< Back
Marrugat J, Elosua R, Grau M, Sayols-Baixeras S, Dégano IR
Prevalence and Prognosis of High-risk Myocardial Infarction Patient Candidates to Extended Antiplatelet Therapy.
Rev Esp Cardiol (Engl Ed). 2016 May;69(5):480-7, PMID: 27062680
Secondary prevention in myocardial infarction patients is paramount to prevent recurrences. Dual antiplatelet therapy has been shown to reduce the risk of subsequent events up to 1 year and beyond in the PEGASUS-TIMI 54 trial. This study aimed to estimate the annual number of myocardial infarction patients with PEGASUS characteristics in Spain and to analyze short- and long-term outcomes in these patients.
CARDIAC & CARDIOVASCULAR SYSTEMS
An initiative of
